Literature DB >> 32223541

Stroke prevention and control system in China: CSPPC-Stroke Program.

Bao-Hua Chao1, Feng Yan2, Yang Hua2, Jian-Min Liu3, Yi Yang4, Xun-Ming Ji2, Bin Peng5, Guo-Guang Zhao2, Yong-Jun Wang6, De-Zhi Kang7, Yi-Long Wang6, Jin-Sheng Zeng8, Lan Chu9, Tian-Xiao Li10, Yu-Ming Xu11, Ming Liu12, Li He12, Yun Xu13, Jian Wu14, Min Lou15, Wei Yue16, Lei Cao1, Wen-Jun Tu1,17,18, Long-De Wang1,19.   

Abstract

In China, stroke is a major cause of mortality, and long-term physical and cognitive impairment. To meet this challenge, the Ministry of Health China Stroke Prevention Project Committee (CSPPC) was established in April 2011. This committee actively promotes stroke prevention and control in China. With government financial support of 838.4 million CNY, 8.352 million people from 536 screening points in 31 provinces have received stroke screening and follow-up over the last seven years (2012-2018). In 2016, the CSPPC issued a plan to establish stroke centers. To shorten the pre-hospital period, the CSPPC established a stroke center network, stroke map, and stroke "Green Channel" to create three 1-h gold rescue circles, abbreviated as "1-1-1" (onset to call time <1 h; pre-hospital transfer time < 1 h, and door-to-needle time < 1 h). From 2017 to 2018, the median door-to-needle time dropped by 4.0% (95% confidence interval (CI), 1.4-9.4) from 50 min to 48 min, and the median onset-to-needle time dropped by 2.8% (95% CI, 0.4-5.2) from 180 min to 175 min. As of 31 December 2018, the CSPPC has established 380 stroke centers in mainland China. From 1 November 2018, the CSPPC has monitored the quality of stroke care in stroke center hospitals through the China Stroke Data Center Data Reporting Platform. The CSPPC Stroke program has led to a significant improvement in stroke care. This program needs to be further promoted nationwide.

Entities:  

Keywords:  China; Stroke; stroke center; stroke prevention and control system

Mesh:

Year:  2020        PMID: 32223541     DOI: 10.1177/1747493020913557

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  58 in total

1.  Stroke-unit care for stroke patients in China: the results from Bigdata Observatory platform for Stroke of China.

Authors:  Wen-Jun Tu; Feng Yan; Bao-Hua Chao; Xun-Ming Ji; Longde Wang
Journal:  J Neurol       Date:  2021-04-22       Impact factor: 4.849

2.  Telestroke for the Treatment of Ischemic Stroke in Western China During the COVID-19 Pandemic: A Multicenter Observational Study.

Authors:  Ning Chen; Xintong Wu; Muke Zhou; Rongdong Yang; Daofeng Chen; Ming Liao; Yongyi Deng; Zhen Hong; Dong Zhou; Li He
Journal:  Front Neurol       Date:  2022-01-31       Impact factor: 4.003

3.  Status of hyperhomocysteinemia in China: results from the China Stroke High-risk Population Screening Program, 2018.

Authors:  Wenjun Tu; Feng Yan; Baohua Chao; Xunming Ji; Longde Wang
Journal:  Front Med       Date:  2021-12-10       Impact factor: 4.592

4.  Thrombolytic DNT and fatality and disability rates in acute ischemic stroke: a study from Bigdata Observatory Platform for Stroke of China.

Authors:  Wen-Jun Tu; Xun-Ming Ji; Long-De Wang; Feng Yan; Bao-Hua Chao; Lin Ma
Journal:  Neurol Sci       Date:  2021-09-03       Impact factor: 3.307

5.  Stroke severity modified the effect of chronic atrial fibrillation on the outcome of thrombolytic therapy.

Authors:  Rui Shao; Zengna Wang; Hongfeng Shi; Yan Li; Yingle Zhuang; Juan Xu; Min Xu
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

6.  Evolution of ischemic stroke drug clinical trials in mainland China from 2005 to 2021.

Authors:  Chunrui Bo; Tianqi Wang; Chengbei Hou; Jinming Han; Lixia Chen; Huixue Zhang; Lihua Wang; Hongyan Li
Journal:  CNS Neurosci Ther       Date:  2022-06-01       Impact factor: 7.035

7.  Circular RNA FUNDC1 for Prediction of Acute Phase Outcome and Long-Term Survival of Acute Ischemic Stroke.

Authors:  Juan Zu; Lei Zuo; Lin Zhang; Zan Wang; Yachen Shi; Lihua Gu; Zhijun Zhang
Journal:  Front Neurol       Date:  2022-06-03       Impact factor: 4.086

8.  Endovascular Thrombectomy Versus Bridging Thrombolysis: Real-World Efficacy and Safety Analysis Based on a Nationwide Registry Study.

Authors:  Chang Geng; Sheng-De Li; Ding-Ding Zhang; Lin Ma; Guo-Wei Liu; Li-Qun Jiao; Jian-Min Liu; Wen-Huo Chen; Wu-Sheng Zhu; Chang-Ming Wen; Bin Peng
Journal:  J Am Heart Assoc       Date:  2021-01-26       Impact factor: 5.501

9.  Serum Interleukin-37 Increases in Patients after Ischemic Stroke and Is Associated with Stroke Recurrence.

Authors:  Ying Zhang; Chengbi Xu; Haitao Wang; Shanji Nan
Journal:  Oxid Med Cell Longev       Date:  2021-04-13       Impact factor: 6.543

10.  The Prognostic Determinant of Interleukin-10 in Patients with Acute Ischemic Stroke: An Analysis from the Perspective of Disease Management.

Authors:  Wen Sun; Shuhui Wang; Shanji Nan
Journal:  Dis Markers       Date:  2021-07-17       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.